Modulation of nigrostriatal dopaminergic transmission by antisense oligodeoxynucleotide against brain-derived neurotrophic factor

Neurochemical Research

Volumn 23, Issue 4, 1998, Pages 525-532

  Lau, Yuen Sum ^a   Hao, Ruyi ^b   Fung, Yiu K ^c   Fu, Liu Song ^b   Bishop, John F ^d   Pfeiffer, Ronald F ^b   Mouradian, M Maral ^d  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Antisense oligodeoxynucleotide; Brain derived neurotrophic factor; Dopaminergic transmission; Rat; Striatum; Susbtantia nigra pars compacta

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BRAIN DERIVED GROWTH FACTOR;

ANIMAL TISSUE; ARTICLE; DOPAMINERGIC NERVE CELL; GROWTH REGULATION; NERVE CELL DIFFERENTIATION; NEUROTRANSMISSION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; PROTEIN TARGETING; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CORPUS STRIATUM; DOPAMINE; EMBRYO; HYBRID CELLS; KINETICS; MALE; MESENCEPHALON; NEUROBLASTOMA; NEURONS; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 0031956007     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022482518292     Document Type: Article

References (26)

1. Glass, D. J., and Yancopoulos, G. D. 1993. The neurotrophins and their receptors. Trends Cell. Biol. 3:262-268.
2. Knüsel, B., Winslow, J. W., Rosenthal, A., Burton, L. E., Seid, D. P., Nikolics, K., and Hefti, F. 1991. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin-3. Proc. Natl. Acad. Sci. USA 88:961-965.
3. Hyman, C., Hofer, M., Barde, Y. A., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., and Lindsay, R. M. 1991. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-233.
4. Spina, M. B., Squinto, S. P., Miller, J., Lindsay, R. M., and Hyman, C. 1992. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system. J. Neurochem. 59:99-106.
5. Acheson, A., Conover, J. C., Fandl, J. P., DeChiara, T. M., Russell, M., Thadani, A., Squinto, S. P., Yancopoulos, G. D., and Lindsay, R. M. 1995. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374:450-453.
6. Mufson, E. J., Kroin, J. S., Sobreviela, T., Burke, M. A., Kordower, J. H., Penn, R. D., and Miller, A. 1994. Intrastriatal infusions of brain-derived neurotrophic factor: Retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat. Experimental Neurology 129:15-26.
7. Altar, C. A., Boylan, C. B., Jackson, C., Hershenson, S., Miller, J., Wiegand, S. J., Linsay, R. M., and Hyman, C. 1992. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc. Natl. Acad. Sci. USA 89:11347-11351.
8. Shults, C. W., Matthews, R. T., Altar, C. A., Hill, L. R., and Langlais, P. J. 1994. A single intramesencephalic injection of brain-derived neurotrophic factor induces persistent rotational asymmetry in rats. Experimental Neurology 125:183-194.
9. Ernfors, P., Lee, K.-F., and Jaenisch, R. 1994. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368:147-150.
10. Jones, K. R., Farifias, I., Backus, C., and Reichardt, L. F. 1994. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76: 989-999.
11. Maisonpierre, P. C., LeBeau, M. M., Espinosa, R., Ip, N. Y., Belluscio, L., De La Monte, S., Squinto, S., Furth, M. E., and Yancopoulos, G. D. 1991. Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 10:558-568.
12. Sambrook, J., Fritsch, E. F., and Maniatas, T. 1989. In Molecular Cloning: A Laboratory Manual, 2nd Ed., pp. 16.59-16.67., Cold Spring Harbor Lab., Cold Spring Harbor, NY.
13. Crawford, G. Jr., Le, W. D., Smith, R. G., Xie, W. J., Stefani, E., and Appel, S. H. 1992. A novel N18TG2 X mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J. Neurosci. 12:3392-3398.
14. Jungbluth, S., Bailey, K., and Barde, Y. A. 1994. Purification and characterization of a brain-derived neurotrophic factor/neurotrophin-3 (BDNF/NT-3) heterodimer. Eur. J. Biochem. 221:677-685.
15. Yan, Q., Rosenfeld, R., Matheson, C. R., Hawkins, N., Lopez, O. T., Bennett, L., and Welcher, A. A. 1997. Expression of brain-derived neurotrophic factor (BDNF) protein in the adult rat central nervous system. Neuroscience 78:431-448.
16. Hao, R. Y., Norgren, R. B. Jr., Lau, Y.-S., and Pfeiffer, R. F. 1995. Cerebrospinal fluid of Parkinson's disease patients inhibits the growth and function of dopaminergic neurons in culture. Neurology 45:138-142.
17. Prochiantz, A., Di Porzio, U., Kato, A., Berger, B., and Glowinski, J. 1979. In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. Proc. Natl. Acad. Sci. USA 76:5387-5391.
18. Paxinos, G., and Watson, C. 1982. The rat brain in stereotaxic coordinates. Academic Press, New York.
19. 1 agonist. J. Neurochem. 60:768-771.
20. Lapchak, P. A., Beck, K. D., Araujo, D. M., Irwin, I., Langston, J. W., and Hefti, F. 1993. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial fore-brain bundle transection. Neuroscience 53:639-650.
21. Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S., and Collins, F. 1993. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
22. Tomozawa, Y., and Appel, S. H. 1986. Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro. Brain Res. 399:111-124.
23. Carvey, P. M., Ptak, L. R., Kao, L., and Klawans, H. L. 1989. Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in cultures of rostral mesencephalic tegmentum. Clin. Neuropharmacol. 12:425-434.
24. Niijima, K., Araki, M., Ogawa, M., Nagatsu, I., Sato, F., Kimura, H., and Yoshida, M. 1990. Enhanced survival of cultured dopamine neurons by treatment with soluble extracts from chemically deafferentiated striatum of adult rat brain. Brain Res. 528:151-154.
25. Tomac, A., Lindqvist, E., Lin, L.-F. H., Ogren, S. O., Young, D., Hoffer, B. J., and Olson, L. 1995. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373: 335-339.
26. Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., Hoffer, B. J., and Gerhardt, G. A. 1996. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380:252-255.